BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet. 2002;359:14-22. [PMID: 11809181 DOI: 10.1016/s0140-6736(02)07273-2] [Cited by in Crossref: 526] [Cited by in F6Publishing: 145] [Article Influence: 27.7] [Reference Citation Analysis]
Number Citing Articles
1 Singh SP, Ahuja V, Ghoshal UC, Makharia G, Dutta U, Zargar SA, Venkataraman J, Dutta AK, Mukhopadhyay AK, Singh A, Thapa BR, Vaiphei K, Sathiyasekaran M, Sahu MK, Rout N, Abraham P, Dalai PC, Rathi P, Sinha SK, Bhatia S, Patra S, Ghoshal U, Poddar U, Mouli VP, Kate V. Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology. Indian J Gastroenterol 2021. [PMID: 34219211 DOI: 10.1007/s12664-021-01186-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772-781. [PMID: 17170018 DOI: 10.1136/gut.2006.101634.] [Reference Citation Analysis]
3 Vonkeman H, Meek I, van de Laar M. Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin. Drug Healthc Patient Saf 2010;2:191-204. [PMID: 21701631 DOI: 10.2147/DHPS.S7206] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Coblijn UK, Goucham AB, Lagarde SM, Kuiken SD, van Wagensveld BA. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24:299-309. [PMID: 24234733 DOI: 10.1007/s11695-013-1118-5] [Cited by in Crossref: 111] [Cited by in F6Publishing: 72] [Article Influence: 15.9] [Reference Citation Analysis]
5 Zullo A, Hassan C, Campo SM, Morini S. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies. Drugs Aging. 2007;24:815-828. [PMID: 17896831 DOI: 10.2165/00002512-200724100-00003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
6 Hung IF, Wong BC. Assessing the risks and benefits of treating Helicobacter pylori infection. Therap Adv Gastroenterol. 2009;2:141-147. [PMID: 21180540 DOI: 10.1177/1756283x08100279] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
7 Lanas A. Prevention and treatment of NSAID-induced gastroduodenal injury. Curr Treat Options Gastroenterol 2006;9:147-56. [PMID: 16539875 DOI: 10.1007/s11938-006-0033-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
8 Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017;112:212-239. [PMID: 28071659 DOI: 10.1038/ajg.2016.563] [Cited by in Crossref: 515] [Cited by in F6Publishing: 369] [Article Influence: 128.8] [Reference Citation Analysis]
9 Fukuda S, Hosaka S, Ozawa N, Akita S, Kashima T, Kimura S, Akiyama J, Mizoue T. Gastric injury caused by low-dose aspirin therapy in consecutive Japanese patients: a prospective study. Gen Thorac Cardiovasc Surg. 2012;60:275-279. [PMID: 22453536 DOI: 10.1007/s11748-011-0886-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 McEvoy L, Carr DF, Pirmohamed M. Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity. Front Pharmacol 2021;12:684162. [PMID: 34234675 DOI: 10.3389/fphar.2021.684162] [Reference Citation Analysis]
11 Lanas A, García-Rodríguez LA, Arroyo MT, Gomollón F, Feu F, González-Pérez A, Zapata E, Bástida G, Rodrigo L, Santolaria S. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006;55:1731-1738. [PMID: 16687434 DOI: 10.1136/gut.2005.080754] [Cited by in Crossref: 335] [Cited by in F6Publishing: 267] [Article Influence: 22.3] [Reference Citation Analysis]
12 Prabhu V, Shivani A. An overview of history, pathogenesis and treatment of perforated peptic ulcer disease with evaluation of prognostic scoring in adults. Ann Med Health Sci Res 2014;4:22-9. [PMID: 24669326 DOI: 10.4103/2141-9248.126604] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 5.9] [Reference Citation Analysis]
13 Peura DA, Goldkind L. Balancing the gastrointestinal benefits and risks of nonselective NSAIDs. Arthritis Res Ther 2005;7 Suppl 4:S7-13. [PMID: 16168079 DOI: 10.1186/ar1793] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
14 Kim Y, Yokoyama S, Watari J, Hori K, Yamasaki T, Okugawa T, Toyoshima F, Kondo T, Sakurai J, Tanaka J, Tomita T, Oshima T, Fukui H, Abe T, Matsumoto T, Miwa H. Endoscopic and clinical features of gastric ulcers in Japanese patients with or without Helicobacter pylori infection who were using NSAIDs or low-dose aspirin. J Gastroenterol 2012;47:904-11. [PMID: 22350702 DOI: 10.1007/s00535-012-0553-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
15 Bae S, Shim KN, Kim N, Kang JM, Kim DS, Kim KM, Cho YK, Jung SW. Incidence and short-term mortality from perforated peptic ulcer in Korea: a population-based study. J Epidemiol 2012;22:508-16. [PMID: 22955110 DOI: 10.2188/jea.je20120056] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
16 Luo JC, Leu HB, Huang KW, Huang CC, Hou MC, Lin HC, Lee FY, Lee SD. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ. 2011;183:E1345-E1351. [PMID: 22083684 DOI: 10.1503/cmaj.110299] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 7.5] [Reference Citation Analysis]
17 Kono Y, Okada H, Takenaka R, Miura K, Kanzaki H, Hori K, Kita M, Tsuzuki T, Kawano S, Kawahara Y, Yamamoto K. Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study. Gut Liver 2016;10:69-75. [PMID: 26087789 DOI: 10.5009/gnl14372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
18 Kakiuchi T, Kumamoto T, Koji A, Matsuo M. Low-dose aspirin-induced gastric mucosal injury after Fontan surgery in an adolescent. Clin Case Rep 2021;9:2460-4. [PMID: 33936713 DOI: 10.1002/ccr3.4070] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Yang J, Zhou X, Liu X, Ling Z, Ji F. Role of the Gastric Microbiome in Gastric Cancer: From Carcinogenesis to Treatment. Front Microbiol 2021;12:641322. [PMID: 33790881 DOI: 10.3389/fmicb.2021.641322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
20 Georgopoulos SD, Michopoulos S, Rokkas T, Apostolopoulos P, Giamarellos E, Kamberoglou D, Mentis A, Triantafyllou K. Hellenic consensus on Helicobacter pylori infection. Ann Gastroenterol 2020;33:105-24. [PMID: 32127732 DOI: 10.20524/aog.2020.0446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Keikha M, Karbalaei M. EPIYA motifs of Helicobacter pylori cagA genotypes and gastrointestinal diseases in the Iranian population: a systematic review and meta-analysis. New Microbes New Infect 2021;41:100865. [PMID: 33912350 DOI: 10.1016/j.nmni.2021.100865] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Blandizzi C, Tuccori M, Colucci R, Gori G, Fornai M, Antonioli L, Ghisu N, Del Tacca M. Clinical efficacy of esomeprazole in the prevention and healing of gastrointestinal toxicity associated with NSAIDs in elderly patients. Drugs Aging. 2008;25:197-208. [PMID: 18331072 DOI: 10.2165/00002512-200825030-00003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
23 Usta M, Urganci N. Upper Gastrointestinal Bleeding in Children: The Role of Helicobacter pylori Infection and Non-steroidal Anti-inflammatory Drug Use. West Indian Med J. 2015;64. [PMID: 26360683 DOI: 10.7727/wimj.2014.130] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Hunt RH, Camilleri M, Crowe SE, El-Omar EM, Fox JG, Kuipers EJ, Malfertheiner P, McColl KE, Pritchard DM, Rugge M, Sonnenberg A, Sugano K, Tack J. The stomach in health and disease. Gut. 2015;64:1650-1668. [PMID: 26342014 DOI: 10.1136/gutjnl-2014-307595] [Cited by in Crossref: 149] [Cited by in F6Publishing: 115] [Article Influence: 24.8] [Reference Citation Analysis]
25 Süsstrunk J, Wartmann L, Mattiello D, Köstler T, Zingg U. Incidence and Prognostic Factors for the Development of Symptomatic and Asymptomatic Marginal Ulcers After Roux-en-Y Gastric Bypass Procedures. Obes Surg 2021;31:3005-14. [PMID: 33761070 DOI: 10.1007/s11695-021-05363-4] [Reference Citation Analysis]
26 Ji KY, Hu FL. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases. World J Gastroenterol 2006;12:3789-92. [PMID: 16804960 DOI: 10.3748/wjg.v12.i24.3789] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
27 Papatheodoridis GV, Archimandritis AJ. Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users. World J Gastroenterol 2005;11:3811-6. [PMID: 15991274 DOI: 10.3748/wjg.v11.i25.3811] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
28 Sugimoto M, Toda Y, Hori M, Mitani A, Ichihara T, Sekine S, Kaku S, Otsuka N, Matsumoto H. Topical Anti-Inflammatory and Analgesic Effects of Multiple Applications of S(+)-Flurbiprofen Plaster (SFPP) in a Rat Adjuvant-Induced Arthritis Model. Drug Dev Res 2016;77:206-11. [PMID: 27241582 DOI: 10.1002/ddr.21314] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
29 Luo JC, Leu HB, Huang KW, Huang CC, Hou MC, Lin HC, Lee FY, Lee SD. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ. 2011;183:E1345-E1351. [PMID: 22083684 DOI: 10.1503/cmaj] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Boyapati R, Ong SY, Ye B, Kruavit A, Lee N, Vaughan R, Nandurkar S, Gibson P, Garg M. One fifth of hospitalizations for peptic ulcer-related bleeding are potentially preventable. World J Gastroenterol. 2014;20:10504-10511. [PMID: 25132768 DOI: 10.3748/wjg.v20.i30.10504] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
31 Huang X, Qu X, Yan W, Huang Y, Cai M, Hu B, Wu L, Lin H, Chen Z, Zhu C. Iron deficiency anaemia can be improved after eradication of Helicobacter pylori. Postgrad Med J. 2010;86:272-278. [PMID: 20448223 DOI: 10.1136/pgmj.2009.089987] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
32 Kao LT, Tsai MC, Lin HC, Pai F, Lee CZ. Weekly pattern of emergency room admissions for peptic ulcers: a population-based study. World J Gastroenterol. 2015;21:3344-3350. [PMID: 25805943 DOI: 10.3748/wjg.v21.i11.3344] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Zullo A, Hassan C, Oliveti D, Chiriatti A, Chiuri DA, Marotti G, Morelli L, Morini S. Helicobacter pylori management in non-steroidal anti-inflammatory drug therapy patients in primary care. Intern Emerg Med 2012;7:331-5. [PMID: 21451987 DOI: 10.1007/s11739-011-0578-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
34 Gurusamy KS, Pallari E. Medical versus surgical treatment for refractory or recurrent peptic ulcer. Cochrane Database Syst Rev. 2016;3:CD011523. [PMID: 27025289 DOI: 10.1002/14651858.cd011523.pub2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
35 Richy F, Bruyere O, Ethgen O, Rabenda V, Bouvenot G, Audran M, Herrero-Beaumont G, Moore A, Eliakim R, Haim M, Reginster JY. Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann Rheum Dis 2004;63:759-66. [PMID: 15194568 DOI: 10.1136/ard.2003.015925] [Cited by in Crossref: 147] [Cited by in F6Publishing: 109] [Article Influence: 8.6] [Reference Citation Analysis]
36 Wang J, Wang WH, Li J, Liu FX. Celecoxib inhibits Helicobacter pylori colonization-related factors. World J Gastroenterol 2010;16:846-53. [PMID: 20143463 DOI: 10.3748/wjg.v16.i7.846] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
37 Brooks J, Warburton R, Beales IL. Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance. Ther Adv Chronic Dis. 2013;4:206-222. [PMID: 23997925 DOI: 10.1177/2040622313492188] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
38 Shin JM, Vagin O, Munson K, Kidd M, Modlin IM, Sachs G. Molecular mechanisms in therapy of acid-related diseases. Cell Mol Life Sci 2008;65:264-81. [PMID: 17928953 DOI: 10.1007/s00018-007-7249-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
39 Niv Y, Niv G, Koren R. 13C-urea breath test for diagnosis of Helicobacter pylori infection in the elderly. Dig Dis Sci. 2004;49:1840-1844. [PMID: 15628714 DOI: 10.1007/s10620-004-9581-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
40 Chen WC, Li YD, Chiang PH, Tsay FW, Chan HH, Tsai WL, Tsai TJ, Wang EM, Cheng JS, Lai KH. Comparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic ulcers/erosions in long-term low-dose aspirin users: a retrospective cohort study. Biomed Res Int 2014;2014:693567. [PMID: 25295267 DOI: 10.1155/2014/693567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
41 Usui Y, Matsuo K, Oze I, Ugai T, Koyanagi Y, Maeda Y, Ito H, Hishida A, Takeuchi K, Tamura T, Tsukamoto M, Kadomatsu Y, Hara M, Nishida Y, Shimoshikiryo I, Takezaki T, Ozaki E, Matsui D, Watanabe I, Suzuki S, Watanabe M, Nakagawa-Senda H, Mikami H, Nakamura Y, Arisawa K, Uemura H, Kuriki K, Takashima N, Kadota A, Ikezaki H, Murata M, Nakatochi M, Momozawa Y, Kubo M, Wakai K. Impact of PSCA Polymorphisms on the Risk of Duodenal Ulcer. J Epidemiol 2021;31:12-20. [PMID: 31839644 DOI: 10.2188/jea.JE20190184] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Qu XH, Huang XL, Xiong P, Zhu CY, Huang YL, Lu LG, Sun X, Rong L, Zhong L, Sun DY. Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J Gastroenterol. 2010;16:886-896. [PMID: 20143469 DOI: 10.3748/wjg.v16.i7.886] [Cited by in F6Publishing: 49] [Reference Citation Analysis]
43 Scheiman JM, Fendrick AM. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs. Arthritis Res Ther 2005;7 Suppl 4:S23-9. [PMID: 16168078 DOI: 10.1186/ar1795] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
44 Kawasaki K, Kurahara K, Yanai S, Kochi S, Fuchigami T, Matsumoto T. Low-Dose Aspirin and Non-steroidal Anti-inflammatory Drugs Increase the Risk of Bleeding in Patients with Gastroduodenal Ulcer. Dig Dis Sci 2015;60:1010-5. [PMID: 25366148 DOI: 10.1007/s10620-014-3415-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
45 Kanno T, Moayyedi P. Who Needs Gastroprotection in 2020? Curr Treat Options Gastroenterol 2020;:1-17. [PMID: 33199955 DOI: 10.1007/s11938-020-00316-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
46 Naesdal J, Brown K. NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options. Drug Saf 2006;29:119-32. [PMID: 16454539 DOI: 10.2165/00002018-200629020-00002] [Cited by in Crossref: 76] [Cited by in F6Publishing: 54] [Article Influence: 5.1] [Reference Citation Analysis]
47 Huang KW, Leu HB, Luo JC, Chan WL, Hou MC, Lin HC, Lee FY, Kuan YC. Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis. Dig Dis Sci. 2014;59:807-813. [PMID: 24318806 DOI: 10.1007/s10620-013-2973-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
48 Manguso F, Riccio E, de Nucci G, Aiezza ML, Amato G, Degl'Innocenti L, Piccirillo MM, De Dominicis G, Santoro T, Trimarco E, Balzano A. Helicobacter pylori infection in bleeding peptic ulcer patients after non-steroidal antiinflammatory drug consumption. World J Gastroenterol 2011;17:4509-16. [PMID: 22110282 DOI: 10.3748/wjg.v17.i40.4509] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
49 Shimamoto T, Yamamichi N, Kodashima S, Takahashi Y, Fujishiro M, Oka M, Mitsushima T, Koike K. No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan. PLoS One 2013;8:e65996. [PMID: 23776588 DOI: 10.1371/journal.pone.0065996] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
50 Tai FWD, McAlindon ME. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract. Clin Med (Lond) 2021;21:131-4. [PMID: 33762373 DOI: 10.7861/clinmed.2021-0039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Egan BJ, O'Connor HJ, O'Morain CA. What is new in the management of Helicobacter pylori? Ir J Med Sci 2008;177:185-8. [PMID: 18636309 DOI: 10.1007/s11845-008-0173-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
52 Reshetnyak VI, Burmistrov AI, Maev IV. Helicobacter pylori: Commensal, symbiont or pathogen? World J Gastroenterol 2021;27:545-60. [PMID: 33642828 DOI: 10.3748/wjg.v27.i7.545] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
53 Kim HC, Lee MC, Moon YW, Seo SS, Lee KW, Lee JH, Choi CH. The Pattern of Use of Oral NSAIDs with or without Co-prescription of Gastroprotective Agent for Arthritic Knee by Korean Practitioners. Knee Surg Relat Res 2011;23:203-7. [PMID: 22570835 DOI: 10.5792/ksrr.2011.23.4.203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
54 Ahmed A, Stanley AJ. Acute upper gastrointestinal bleeding in the elderly: aetiology, diagnosis and treatment. Drugs Aging. 2012;29:933-940. [PMID: 23192436 DOI: 10.1007/s40266-012-0020-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
55 Conaghan PG. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int 2012;32:1491-502. [PMID: 22193214 DOI: 10.1007/s00296-011-2263-6] [Cited by in Crossref: 200] [Cited by in F6Publishing: 151] [Article Influence: 20.0] [Reference Citation Analysis]
56 Kanabar D. A practical approach to the treatment of low-risk childhood fever. Drugs R D 2014;14:45-55. [PMID: 24916274 DOI: 10.1007/s40268-014-0052-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
57 Lee YC, Liou JM, Wu MS, Wu CY, Lin JT. Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone. Therap Adv Gastroenterol. 2008;1:111-120. [PMID: 21180520 DOI: 10.1177/1756283x08094880] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
58 Bashinskaya B, Nahed BV, Redjal N, Kahle KT, Walcott BP. Trends in Peptic Ulcer Disease and the Identification of Helicobacter Pylori as a Causative Organism: Population-based Estimates from the US Nationwide Inpatient Sample. J Glob Infect Dis. 2011;3:366-370. [PMID: 22224001 DOI: 10.4103/0974-777x.91061] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
59 Hawkey CJ, Langman MJ. Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors. Gut 2003;52:600-8. [PMID: 12631678 DOI: 10.1136/gut.52.4.600] [Cited by in Crossref: 119] [Cited by in F6Publishing: 83] [Article Influence: 6.6] [Reference Citation Analysis]
60 Vachhani R, Bouhaidar D, Zfass A, Sandhu B, Nawras A. Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reduction. Ther Clin Risk Manag 2010;6:287-92. [PMID: 20596506 DOI: 10.2147/tcrm.s7207] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Yamamoto K, Takahashi O, Arioka H, Kobayashi D. Evaluation of risk factors for perforated peptic ulcer. BMC Gastroenterol 2018;18:28. [PMID: 29448921 DOI: 10.1186/s12876-018-0756-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Forgerini M, Urbano G, de Nadai TR, Batah SS, Fabro AT, Mastroianni PC. Genetic Variants in PTGS1 and NOS3 Genes Increase the Risk of Upper Gastrointestinal Bleeding: A Case-Control Study. Front Pharmacol 2021;12:671835. [PMID: 34290607 DOI: 10.3389/fphar.2021.671835] [Reference Citation Analysis]
63 Sakamoto C, Sugano K, Ota S, Sakaki N, Takahashi S, Yoshida Y, Tsukui T, Osawa H, Sakurai Y, Yoshino J. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol. 2006;62:765-772. [PMID: 16821007 DOI: 10.1007/s00228-006-0171-6] [Cited by in Crossref: 100] [Cited by in F6Publishing: 73] [Article Influence: 6.7] [Reference Citation Analysis]
64 Ahmed S, Salih M, Jafri W, Ali Shah H, Hamid S. Helicobacter pylori infection: approach of primary care physicians in a developing country. BMC Gastroenterol 2009;9:23. [PMID: 19358721 DOI: 10.1186/1471-230X-9-23] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
65 Gayam V, Mandal AK, Khalid M, Kaler J, Thapa S, Garlapati P, Gill A, Alex R, Shrestha B. A Rare Case of Systemic Lupus Erythematosus with Gastric Ulcer and Acute Pancreatitis: A Case Report and Literature Review. Gastroenterology Res 2018;11:321-5. [PMID: 30116433 DOI: 10.14740/gr1048w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
66 Bakkevold KE. Time trends in incidence of peptic ulcer bleeding and associated risk factors in Norway 1985-2008. Clin Exp Gastroenterol 2010;3:71-7. [PMID: 21694849 DOI: 10.2147/ceg.s10921] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
67 Battglia G, Lecis E, Donisi PM. Lymphoid follicule in gastric mucosa of Helicobacter pylori infected patients regression 6-12 months after eradication. Gut. 1995;37:76. [DOI: 10.1128/IAI.00801-13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
68 Tsumura H, Fujita T, Tamura I, Morita Y, Yoshida M, Toyonaga T, Mukai H, Inokuchi H, Kutsumi H, Azuma T. Association between adherence to evidence-based guidelines for the prescription of non-steroidal anti-inflammatory drugs and the incidence of gastric mucosal lesions in Japanese patients. J Gastroenterol 2010;45:944-51. [PMID: 20499110 DOI: 10.1007/s00535-010-0236-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
69 Shea BJ, Bouter LM, Peterson J, Boers M, Andersson N, Ortiz Z, Ramsay T, Bai A, Shukla VK, Grimshaw JM. External validation of a measurement tool to assess systematic reviews (AMSTAR). PLoS One. 2007;2:e1350. [PMID: 18159233 DOI: 10.1371/journal.pone.0001350] [Cited by in Crossref: 340] [Cited by in F6Publishing: 299] [Article Influence: 24.3] [Reference Citation Analysis]
70 Boukthir S, Mazigh SM, Kalach N, Bouyahya O, Sammoud A. The effect of non-steroidal anti-inflammatory drugs and Helicobacter pylori infection on the gastric mucosa in children with upper gastrointestinal bleeding. Pediatr Surg Int. 2010;26:227-230. [PMID: 19823852 DOI: 10.1007/s00383-009-2492-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
71 Namba T, Hoshino T, Suemasu S, Takarada-Iemata M, Hori O, Nakagata N, Yanaka A, Mizushima T. Suppression of expression of endoplasmic reticulum chaperones by Helicobacter pylori and its role in exacerbation of non-steroidal anti-inflammatory drug-induced gastric lesions. J Biol Chem 2010;285:37302-13. [PMID: 20861013 DOI: 10.1074/jbc.M110.148882] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
72 Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007;42:1-15. [PMID: 17322988 DOI: 10.1007/s00535-006-1990-z] [Cited by in Crossref: 113] [Cited by in F6Publishing: 105] [Article Influence: 8.1] [Reference Citation Analysis]
73 Cizginer S, Ordulu Z, Kadayifci A. Approach to Helicobacter pylori infection in geriatric population. World J Gastrointest Pharmacol Ther. 2014;5:139-147. [PMID: 25133042 DOI: 10.4292/wjgpt.v5.i3.139] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
74 Testerman TL, Morris J. Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World J Gastroenterol. 2014;20:12781-12808. [PMID: 25278678 DOI: 10.3748/wjg.v20.i36.12781] [Cited by in CrossRef: 138] [Cited by in F6Publishing: 115] [Article Influence: 23.0] [Reference Citation Analysis]
75 Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772-781. [PMID: 17170018 DOI: 10.1136/gut.2006.101634] [Cited by in Crossref: 1222] [Cited by in F6Publishing: 1070] [Article Influence: 81.5] [Reference Citation Analysis]
76 Keikha M, Ali-Hassanzadeh M, Karbalaei M. Association of Helicobacter pylori vacA genotypes and peptic ulcer in Iranian population: a systematic review and meta-analysis. BMC Gastroenterol 2020;20:266. [PMID: 32795257 DOI: 10.1186/s12876-020-01406-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
77 Tielemans MM, Eikendal T, Jansen JB, van Oijen MG. Identification of NSAID users at risk for gastrointestinal complications: a systematic review of current guidelines and consensus agreements. Drug Saf 2010;33:443-53. [PMID: 20486727 DOI: 10.2165/11534590-000000000-00000] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
78 Hermansson M, Ekedahl A, Ranstam J, Zilling T. Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002. BMC Gastroenterol 2009;9:25. [PMID: 19379513 DOI: 10.1186/1471-230X-9-25] [Cited by in Crossref: 47] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
79 Chan FK. NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management. Drug Saf. 2005;28:287-300. [PMID: 15783239 DOI: 10.2165/00002018-200528040-00002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
80 Cryer B, Mahaffey KW. Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment. J Multidiscip Healthc 2014;7:137-46. [PMID: 24741318 DOI: 10.2147/JMDH.S54324] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 4.1] [Reference Citation Analysis]
81 Scheiman JM. The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage. Arthritis Res Ther. 2013;15 Suppl 3:S5. [PMID: 24267413 DOI: 10.1186/ar4177] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
82 Kouitcheu Mabeku LB, Eyoum Bille B, Nguepi E. In Vitro and In Vivo Anti-Helicobacter Activities of Eryngium foetidum (Apiaceae), Bidens pilosa (Asteraceae), and Galinsoga ciliata (Asteraceae) against Helicobacter pylori. Biomed Res Int 2016;2016:2171032. [PMID: 27631003 DOI: 10.1155/2016/2171032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
83 Oshima T, Miwa H. Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases. J Neurogastroenterol Motil. 2018;24:334-344. [PMID: 29739175 DOI: 10.5056/jnm18029] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 9.7] [Reference Citation Analysis]
84 Thjodleifsson B. Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors. Drugs Aging 2002;19:911-27. [PMID: 12495367 DOI: 10.2165/00002512-200219120-00003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
85 Sostres C, Gargallo CJ, Lanas A. Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights. World J Gastroenterol. 2014;20:9439-9450. [PMID: 25071338 DOI: 10.3748/wjg.v20.i28.9439] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
86 Lee OY, Kang DH, Lee DH, Chung IK, Jang JY, Kim JI, Cho JW, Rew JS, Lee KM, Kim KO, Choi MG, Lee SW, Lee ST, Kim TO, Shin YW, Seol SY. A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment. Arch Pharm Res 2014;37:1308-16. [PMID: 24871787 DOI: 10.1007/s12272-014-0408-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
87 Siao D, Somsouk M. Helicobacter pylori: evidence-based review with a focus on immigrant populations. J Gen Intern Med. 2014;29:520-528. [PMID: 24065381 DOI: 10.1007/s11606-013-2630-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
88 Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772-781. [PMID: 17170018 DOI: 10.1036/gut.2006.101634] [Reference Citation Analysis]
89 Zapata-Colindres JC, Zepeda-Gómez S, Montaño-Loza A, Vázquez-Ballesteros E, de Jesús Villalobos J, Valdovinos-Andraca F. The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease. Can J Gastroenterol 2006;20:277-80. [PMID: 16609757 DOI: 10.1155/2006/175217] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
90 Budzyński J, Koziński M, Kłopocka M, Kubica JM, Kubica J. Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence. Clin Res Cardiol. 2014;103:855-886. [PMID: 24817551 DOI: 10.1007/s00392-014-0720-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
91 Kaneto C, Toyokawa S, Inoue K, Inoue M, Senba T, Suyama Y, Miyoshi Y, Kobayashi Y. Association between periodontal disease and peptic ulcers among Japanese workers: MY health up study. Glob J Health Sci 2012;4:42-9. [PMID: 22980150 DOI: 10.5539/gjhs.v4n2p42] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
92 Luo JC, Chang FY, Chen TS, Ng YY, Lin HC, Lu CL, Chen CY, Lin HY, Lee SD. Gastric mucosal injury in systemic lupus erythematosus patients receiving pulse methylprednisolone therapy. Br J Clin Pharmacol. 2009;68:252-259. [PMID: 19694746 DOI: 10.1111/j.1365-2125.2009.03445.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
93 Venerito M, Wex T, Malfertheiner P. Nonsteroidal Anti-Inflammatory Drug-Induced Gastroduodenal Bleeding: Risk Factors and Prevention Strategies. Pharmaceuticals (Basel). 2010;3:2225-2237. [PMID: 27713351 DOI: 10.3390/ph3072225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
94 Pasa S, Bayan K, Kucukoner M, Tuzun Y, Altintas A, Cil T, Danis R, Ayyildiz O. The effects of nonsteroidal anti-inflammatory drugs on platelet function and severity of upper gastrointestinal haemorrhage. J Thromb Thrombolysis 2009;28:83-9. [PMID: 18696215 DOI: 10.1007/s11239-008-0263-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
95 Sostres C, Gargallo CJ, Lanas A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther 2013;15 Suppl 3:S3. [PMID: 24267289 DOI: 10.1186/ar4175] [Cited by in Crossref: 174] [Cited by in F6Publishing: 128] [Article Influence: 21.8] [Reference Citation Analysis]
96 Yamanaka K, Miyatani H, Yoshida Y, Asabe S, Yoshida T, Nakano M, Obara S, Endo H. Hemorrhagic gastric and duodenal ulcers after the Great East Japan Earthquake Disaster. World J Gastroenterol 2013;19:7426-32. [PMID: 24259974 DOI: 10.3748/wjg.v19.i42.7426] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
97 Goddard AF, Logan RP. Diagnostic methods for Helicobacter pylori detection and eradication. Br J Clin Pharmacol 2003;56:273-83. [PMID: 12919175 DOI: 10.1046/j.1365-2125.2003.01941.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
98 Becker JC, Domschke W, Pohle T. Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond. Br J Clin Pharmacol. 2004;58:587-600. [PMID: 15563357 DOI: 10.1111/j.1365-2125.2004.02198.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
99 Vonkeman HE, Deleest H, van Delaar M, Vanbaarlen J, Steen K, Lems W, Bijlsma J, Kuipers E, Houben H, Janssen M, Dijkmans B. Assessment of Helicobacter pylori eradication in patients on NSAID treatment. BMC Gastroenterol 2012;12:133. [PMID: 23006807 DOI: 10.1186/1471-230X-12-133] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 Bolten WW. Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs. Ann Rheum Dis 2006;65:7-13. [PMID: 15941837 DOI: 10.1136/ard.2005.036269] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
101 Choe AR, Shim KN, Park Y, Song EM, Tae CH, Jung SA. Cost-Effectiveness, Efficacy, and Safety Analysis of Tailored Therapy in Patients with Helicobacter pylori Infection. J Clin Med 2021;10:2619. [PMID: 34198677 DOI: 10.3390/jcm10122619] [Reference Citation Analysis]
102 Hunt R, B Lazebnik L, C Marakhouski Y, Manuc M, Gn R, S Aye K, S Bordin D, V Bakulina N, S Iskakov B, A Khamraev A, M Stepanov Y, Ally R, Garg A. International Consensus on Guiding Recommendations for Management of Patients with Nonsteroidal Antiinflammatory Drugs Induced Gastropathy-ICON-G. Euroasian J Hepatogastroenterol 2018;8:148-60. [PMID: 30828557 DOI: 10.5005/jp-journals-10018-1281] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 4.5] [Reference Citation Analysis]
103 Arai J, Niikura R, Hayakawa Y, Sato H, Kawahara T, Honda T, Hasatani K, Yoshida N, Nishida T, Sumiyoshi T, Kiyotoki S, Ikeya T, Arai M, Suzuki N, Tsuji Y, Yamada A, Koike K. Nonsteroidal anti-inflammatory drugs prevent gastric cancer associated with the use of proton pump inhibitors after Helicobacter pylori eradication. JGH Open 2021;5:770-7. [PMID: 34263071 DOI: 10.1002/jgh3.12583] [Reference Citation Analysis]
104 Lanas A. A review of the gastrointestinal safety data--a gastroenterologist's perspective. Rheumatology (Oxford) 2010;49 Suppl 2:ii3-10. [PMID: 20407138 DOI: 10.1093/rheumatology/keq058] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
105 Lee HL, Chua SS, Mahadeva S. Utilization of gastroprotective strategies for nonsteroidal anti-inflammatory drug-induced gastrointestinal events in a major teaching hospital. Ther Clin Risk Manag 2016;12:1649-57. [PMID: 27877048 DOI: 10.2147/TCRM.S119722] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
106 Li Z, Wang Z, Shen B, Chen C, Ding X, Song H. Effects of aspirin on the gastrointestinal tract: Pros vs. cons. Oncol Lett 2020;20:2567-78. [PMID: 32782574 DOI: 10.3892/ol.2020.11817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Zhang S, Qing Q, Bai Y, Mao H, Zhu W, Chen Q, Zhang Y, Chen Y. Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis. Dig Dis Sci 2013;58:1991-2000. [PMID: 23456504 DOI: 10.1007/s10620-013-2606-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
108 Coblijn UK, Lagarde SM, de Castro SM, Kuiken SD, van Wagensveld BA. Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management. Obes Surg 2015;25:805-11. [PMID: 25381115 DOI: 10.1007/s11695-014-1482-9] [Cited by in Crossref: 62] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
109 Myint T, Shiota S, Vilaichone RK, Ni N, Aye TT, Matsuda M, Tran TT, Uchida T, Mahachai V, Yamaoka Y. Prevalence of Helicobacter pylori infection and atrophic gastritis in patients with dyspeptic symptoms in Myanmar. World J Gastroenterol 2015;21:629-36. [PMID: 25605987 DOI: 10.3748/wjg.v21.i2.629] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
110 Sokic-Milutinovic A, Krstic M, Rozer-Smolovic B, Alempijevic T. Role of Helicobacter pylori infection in gastroduodenal damage in patients starting NSAID therapy: 4 Months follow-up study. Dig Dis Sci. 2010;55:2887-2892. [PMID: 20094785 DOI: 10.1007/s10620-009-1097-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
111 Mizuno M, Yatabe Y, Nawa A, Nakanishi T. Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma. Int J Clin Oncol 2012;17:348-54. [PMID: 21830086 DOI: 10.1007/s10147-011-0299-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
112 Vilaichone RK, Mahachai V, Shiota S, Uchida T, Ratanachu-ek T, Tshering L, Tung NL, Fujioka T, Moriyama M, Yamaoka Y. Extremely high prevalence of Helicobacter pylori infection in Bhutan. World J Gastroenterol. 2013;19:2806-2810. [PMID: 23687418 DOI: 10.3748/wjg.v19.i18.2806] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
113 Uppalapati SS, Boylan JD, Stoltzfus J. Risk factors involved in patients with bleeding peptic ulcers: a case-control study. Dig Dis Sci. 2009;54:593-598. [PMID: 18648934 DOI: 10.1007/s10620-008-0387-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
114 Mejia A, Kraft WK. Acid peptic diseases: pharmacological approach to treatment. Expert Rev Clin Pharmacol. 2009;2:295-314. [PMID: 21822447 DOI: 10.1586/ecp.09.8] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
115 Yoon H, Kim SG, Jung HC, Song IS. High Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-up. Gut Liver. 2013;7:175-181. [PMID: 23560153 DOI: 10.5009/gnl.2013.7.2.175] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
116 Shioi I, Yokoyama N, Hirai M, Komatsu M, Kubota A, Aoki M, Sato D, Otani T. Perforation of anastomotic peptic ulcer following pancreaticoduodenectomy: a report of three cases. BMC Surg 2020;20:79. [PMID: 32306934 DOI: 10.1186/s12893-020-00743-6] [Reference Citation Analysis]
117 Kim JS, Kim JM, Jung HC, Song IS. Helicobacter pylori down-regulates the receptors of vascular endothelial growth factor and angiopoietin in vascular endothelial cells: implications in the impairment of gastric ulcer healing. Dig Dis Sci 2004;49:778-86. [PMID: 15259499 DOI: 10.1023/b:ddas.0000030089.76514.e4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
118 Fischbach W, Malfertheiner P. Helicobacter Pylori Infection. Dtsch Arztebl Int. 2018;115:429-436. [PMID: 29999489 DOI: 10.3238/arztebl.2018.0429] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
119 Ljubičić N, Puljiz Z, Budimir I, Bišćanin A, Bratanić A, Pavić T, Nikolić M, Hrabar D, Supanc V. The influence of etiologic factors on clinical outcome in patients with peptic ulcer bleeding. Dig Dis Sci. 2012;57:3195-3204. [PMID: 22736015 DOI: 10.1007/s10620-012-2273-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
120 Shiotani A, Kamada T, Haruma K. Low-dose aspirin-induced gastrointestinal diseases: past, present, and future. J Gastroenterol. 2008;43:581-588. [PMID: 18709479 DOI: 10.1007/s00535-008-2206-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
121 Li M, Dan W, Zhang H, Yun Y, He Q. Xiao Chai Hu Tang for Peptic Ulcers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med 2021;2021:6693677. [PMID: 34012475 DOI: 10.1155/2021/6693677] [Reference Citation Analysis]
122 Go MF. Diagnosis and Treatment of Helicobacter pylori. Curr Treat Options Gastroenterol. 2005;8:163-174. [PMID: 15769438 DOI: 10.1007/s11938-005-0009-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
123 Watari I, Oka S, Tanaka S, Aoyama T, Imagawa H, Shishido T, Yoshida S, Chayama K. Effectiveness of polaprezinc for low-dose aspirin-induced small-bowel mucosal injuries as evaluated by capsule endoscopy: a pilot randomized controlled study. BMC Gastroenterol 2013;13:108. [PMID: 23826914 DOI: 10.1186/1471-230X-13-108] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
124 Al Batran R, Al-Bayaty F, Abdulla MA, Al-Obaidi MM, Hajrezaei M, Hassandarvish P, Fouad M, Golbabapour S, Talaee S. Gastroprotective effects of Corchorus olitorius leaf extract against ethanol-induced gastric mucosal hemorrhagic lesions in rats. J Gastroenterol Hepatol 2013;28:1321-9. [PMID: 23611708 DOI: 10.1111/jgh.12229] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
125 Yajima H, Yamao J, Fukui H, Takakura Y. Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients: a study using logistic regression analysis. J Orthop Sci 2007;12:341-6. [PMID: 17657553 DOI: 10.1007/s00776-007-1139-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
126 Hiraishi H, Oki R, Tsuchida K, Yoshitake N, Tominaga K, Kusano K, Hashimoto T, Maeda M, Sasai T, Shimada T. Frequency of nonsteroidal anti-inflammatory drug-associated ulcers. Clin J Gastroenterol. 2012;5:171-176. [PMID: 26182316 DOI: 10.1007/s12328-012-0300-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
127 Andoulo FA, Noah DN, Tagni-Sartre M, Ndam EC, Blackett KN. [Epidemiology of infection Helicobacter pylori in Yaoundé: specificity of the African enigma]. Pan Afr Med J 2013;16:115. [PMID: 24778752 DOI: 10.11604/pamj.2013.16.115.3007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
128 Shiota S, Cruz M, Abreu JAJ, Mitsui T, Terao H, Disla M, Iwatani S, Nagashima H, Matsuda M, Uchida T, Tronilo L, Rodríguez E, Yamaoka Y. Virulence genes of Helicobacter pylori in the Dominican Republic. J Med Microbiol 2014;63:1189-96. [PMID: 24965801 DOI: 10.1099/jmm.0.075275-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
129 Grodzinsky E, Hallert C, Faresjö T, Bergfors E, Faresjö AO. Could gastrointestinal disorders differ in two close but divergent social environments? Int J Health Geogr 2012;11:5. [PMID: 22309613 DOI: 10.1186/1476-072X-11-5] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
130 Yamao J, Kikuchi E, Matsumoto M, Nakayama M, Ann T, Kojima H, Mitoro A, Yoshida M, Yoshikawa M, Yajima H, Miyauchi Y, Ono H, Akiyama K, Sakurai G, Kinoshita Y, Haruma K, Takakura Y, Fukui H. Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy). J Gastroenterol 2006;41:1178-85. [PMID: 17287897 DOI: 10.1007/s00535-006-1952-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
131 Lee CW, Sarosi GA. Emergency ulcer surgery. Surg Clin North Am. 2011;91:1001-1013. [PMID: 21889026 DOI: 10.1016/j.suc.2011.06.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
132 Sheu BS, Wu MS, Chiu CT, Lo JC, Wu DC, Liou JM, Wu CY, Cheng HC, Lee YC, Hsu PI, Chang CC, Chang WL, Lin JT. Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale. Helicobacter. 2017;22. [PMID: 28066960 DOI: 10.1111/hel.12368] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
133 Michikawa Y, Yasuda H, Watanabe Y, Oikawa R, Ohishi Y, Maehata T, Itoh F. COX-2 Gene Promoter Methylation in Patients Infected with Helicobacter Pylori. Clin Med Insights Gastroenterol 2013;6:13-9. [PMID: 24833939 DOI: 10.4137/CGast.S11917] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
134 Dore MP, Marras G, Rocchi C, Soro S, Loria MF, Bassotti G, Graham DY, Malaty HM, Pes GM. Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic Sardinian patients. Intern Emerg Med 2015;10:787-94. [PMID: 25739590 DOI: 10.1007/s11739-015-1218-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
135 Minyaylo O, Ponomarenko I, Reshetnikov E, Dvornyk V, Churnosov M. Functionally significant polymorphisms of the MMP-9 gene are associated with peptic ulcer disease in the Caucasian population of Central Russia. Sci Rep 2021;11:13515. [PMID: 34188075 DOI: 10.1038/s41598-021-92527-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Lee SW, Chang CS, Lee TY, Yeh HZ, Tung CF, Peng YC. Risk factors and therapeutic response in Chinese patients with peptic ulcer disease. World J Gastroenterol 2010;16:2017-22. [PMID: 20419840 DOI: 10.3748/wjg.v16.i16.2017] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
137 Yataba I, Otsuka N, Matsushita I, Matsumoto H, Hoshino Y. The efficacy and safety of S-flurbiprofen plaster in the treatment of knee osteoarthritis: a phase II, randomized, double-blind, placebo-controlled, dose-finding study. J Pain Res 2017;10:867-80. [PMID: 28442928 DOI: 10.2147/JPR.S131779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
138 Sanders MK, Peura DA. Helicobacter pylori-Associated Diseases. Curr Gastroenterol Rep. 2002;4:448-454. [PMID: 12441033 DOI: 10.1007/s11894-002-0019-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
139 Plitzko G, Schmutz G, Kröll D, Nett PC, Borbély Y. Ulcer Disease in the Excluded Segments after Roux-en-Y Gastric Bypass: a Current Review of the Literature. Obes Surg 2021;31:1280-9. [PMID: 33230760 DOI: 10.1007/s11695-020-05123-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
140 Vaira D, Vakil N, Rugge M, Gatta L, Ricci C, Menegatti M, Leandro G, Holton J, Russo VM, Miglioli M. Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects. Gut 2003;52:1543-7. [PMID: 14570720 DOI: 10.1136/gut.52.11.1543] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
141 Kuna L, Jakab J, Smolic R, Raguz-Lucic N, Vcev A, Smolic M. Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment Options. J Clin Med 2019;8:E179. [PMID: 30717467 DOI: 10.3390/jcm8020179] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 18.0] [Reference Citation Analysis]
142 Sumanen MP, Koskenvuo MJ, Sillanmäki LH, Mattila KJ. Peptic ulcer and childhood adversities experienced by working-aged people. World J Gastroenterol 2009;15:3405-10. [PMID: 19610142 DOI: 10.3748/wjg.15.3405] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
143 Iwamoto J, Saito Y, Honda A, Matsuzaki Y. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy. World J Gastroenterol. 2013;19:1673-1682. [PMID: 23555156 DOI: 10.3748/wjg.v19.i11.1673] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
144 Cuzick J, Thorat MA, Bosetti C, Brown PH, Burn J, Cook NR, Ford LG, Jacobs EJ, Jankowski JA, La Vecchia C. Estimates of benefits and harms of prophylactic use of aspirin in the general population. Ann Oncol. 2015;26:47-57. [PMID: 25096604 DOI: 10.1093/annonc/mdu225] [Cited by in Crossref: 223] [Cited by in F6Publishing: 174] [Article Influence: 31.9] [Reference Citation Analysis]
145 Kwiatkowska B, Majdan M, Mastalerz-Migas A, Niewada M, Skrzydło-Radomańska B, Mamcarz A. Status of etoricoxib in the treatment of rheumatic diseases. Expert panel opinion. Reumatologia 2017;55:290-7. [PMID: 29491537 DOI: 10.5114/reum.2017.72626] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]